{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:50:12Z","timestamp":1792057812047,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32070662 and 32030063"],"award-info":[{"award-number":["32070662 and 32030063"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97513-2","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T09:18:12Z","timestamp":1744622292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of novel inhibitors targeting Mycobacterium abscessus InhA through virtual screening, docking, and molecular dynamic simulations"],"prefix":"10.1038","volume":"15","author":[{"given":"Munawar","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah R.","family":"Alanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif Iqbal","family":"Sahibzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariyam","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"97513_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-73317-9_92-1","volume-title":"Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays","author":"KK Mak","year":"2022","unstructured":"Mak, K. K., Wong, Y. H. & Pichika, M. R. Artificial intelligence in drug discovery and development. In Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays (eds Hock, F. J. & Pugsley, M. K.) 1\u201338 https:\/\/doi.org\/10.1007\/978-3-030-73317-9_92-1 (Springer International Publishing, 2022)."},{"key":"97513_CR2","doi-asserted-by":"publisher","first-page":"39477","DOI":"10.1039\/C8RA08198K","volume":"8","author":"S Jana","year":"2018","unstructured":"Jana, S., Ganeshpurkar, A. & Kumar Singh, S. Multiple 3D-QSAR modeling, e-pharmacophore, molecular docking, and in vitro study to explore novel ache inhibitors. RSC Adv. 8, 39477\u201339495 (2018).","journal-title":"RSC Adv."},{"key":"97513_CR3","doi-asserted-by":"publisher","first-page":"659997","DOI":"10.3389\/fcimb.2021.659997","volume":"11","author":"L Victoria","year":"2021","unstructured":"Victoria, L., Gupta, A., G\u00f3mez, J. L. & Robledo, J. Mycobacterium abscessus complex: A review of recent developments in an emerging pathogen. Front. Cell. Infect. Microbiol. 11, 659997 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"97513_CR4","doi-asserted-by":"publisher","first-page":"e62443","DOI":"10.1371\/journal.pone.0062443","volume":"8","author":"H Heydari","year":"2013","unstructured":"Heydari, H. et al. MabsBase: A Mycobacterium abscessus genome and annotation database. PLOS ONE. 8, e62443 (2013).","journal-title":"PLOS ONE"},{"key":"97513_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.5588\/ijtld.14.0134","volume":"18","author":"WJ Koh","year":"2014","unstructured":"Koh, W. J., Stout, J. E. & Yew, W. W. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex. Int. J. Tuberc. Lung Dis. 18, 1141\u20131148 (2014).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"97513_CR6","doi-asserted-by":"publisher","unstructured":"Philley, J. V. spsampsps Griffith, D. E. Disease Caused by Mycobacterium Abscessus and Other Rapidly Growing Mycobacteria (RGM). in Nontuberculous Mycobacterial Disease: A Comprehensive Approach to Diagnosis and Management (ed. Griffith, D. E.) 369\u2013399 https:\/\/doi.org\/10.1007\/978-3-319-93473-0_13 (Springer International Publishing, Cham, 2019).","DOI":"10.1007\/978-3-319-93473-0_13"},{"key":"97513_CR7","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2023-0279","author":"M Abbas","year":"2024","unstructured":"Abbas, M. et al. Sources, transmission and hospital-associated outbreaks of nontuberculous mycobacteria: a review. Future Microbiol. https:\/\/doi.org\/10.2217\/fmb-2023-0279 (2024).","journal-title":"Future Microbiol."},{"key":"97513_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41564-021-00963-3","volume":"6","author":"C Ruis","year":"2021","unstructured":"Ruis, C. et al. Dissemination of Mycobacterium abscessus via global transmission networks. Nat. Microbiol. 6, 1279\u20131288 (2021).","journal-title":"Nat. Microbiol."},{"key":"97513_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","volume":"18","author":"MD Johansen","year":"2020","unstructured":"Johansen, M. D., Herrmann, J. L. & Kremer, L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat. Rev. Microbiol. 18, 392\u2013407 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"97513_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley, C. L. et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin. Infect. Dis. 71, e1\u2013e36 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"97513_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jcf.2014.07.004","volume":"14","author":"AL Roux","year":"2015","unstructured":"Roux, A. L. et al. Comparing Mycobacterium Massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. J. Cyst. Fibros. 14, 63\u201369 (2015).","journal-title":"J. Cyst. Fibros."},{"key":"97513_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01879-19","author":"M Richard","year":"2020","unstructured":"Richard, M., Guti\u00e9rrez, A. V. & Kremer, L. Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/aac.01879-19 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"97513_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1100\/tsw.2008.99","volume":"8","author":"MVN de Souza","year":"2008","unstructured":"de Souza, M. V. N. et al. Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis. Sci. World J. 8, 720\u2013751 (2008).","journal-title":"Sci. World J."},{"key":"97513_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/14787210.2023.2224563","volume":"21","author":"M Alcaraz","year":"2023","unstructured":"Alcaraz, M., Edwards, T. E. & Kremer, L. New therapeutic strategies for Mycobacterium abscessus pulmonary diseases \u2013 untapping the mycolic acid pathway. Expert Rev. Anti-infective Therapy. 21, 813\u2013829 (2023).","journal-title":"Expert Rev. Anti-infective Therapy"},{"key":"97513_CR15","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1021\/acsinfecdis.2c00314","volume":"8","author":"M Alcaraz","year":"2022","unstructured":"Alcaraz, M. et al. Efficacy and mode of action of a direct inhibitor of Mycobacterium abscessus InhA. ACS Infect. Dis. 8, 2171\u20132186 (2022).","journal-title":"ACS Infect. Dis."},{"key":"97513_CR16","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1016\/j.bmc.2017.05.015","volume":"25","author":"ND Franz","year":"2017","unstructured":"Franz, N. D. et al. Design, synthesis and evaluation of indole-2-carboxamides with Pan anti-mycobacterial activity. Bioorg. Med. Chem. 25, 3746\u20133755 (2017).","journal-title":"Bioorg. Med. Chem."},{"key":"97513_CR17","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00352","author":"P Bhattarai","year":"2022","unstructured":"Bhattarai, P. et al. Structural determinants of Indole-2-carboxamides: identification of lead acetamides with Pan antimycobacterial activity. J. Med. Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00352 (2022).","journal-title":"J. Med. Chem."},{"key":"97513_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon, S. L. et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J. Comput. Aided Mol. Des. 20, 647\u2013671 (2006).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"97513_CR19","doi-asserted-by":"publisher","first-page":"108488","DOI":"10.1016\/j.jmgm.2023.108488","volume":"122","author":"GL Szwabowski","year":"2023","unstructured":"Szwabowski, G. L., Daigle, B. J., Baker, D. L. & Parrill, A. L. Structure-based pharmacophore modeling 2. Developing a novel framework for structure-based pharmacophore model generation and selection. J. Mol. Graph Model. 122, 108488 (2023).","journal-title":"J. Mol. Graph Model."},{"key":"97513_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley, J. C. et al. Epik: a software program for pKaprediction and protonation state generation for drug-like molecules. J. Comput. Aided Mol. Des. 21, 681\u2013691 (2007).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"97513_CR21","doi-asserted-by":"publisher","first-page":"105242","DOI":"10.1016\/j.bioorg.2021.105242","volume":"115","author":"MS Prasad","year":"2021","unstructured":"Prasad, M. S., Bhole, R. P., Khedekar, P. B. & Chikhale, R. V. Mycobacterium Enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery. Bioorg. Chem. 115, 105242 (2021).","journal-title":"Bioorg. Chem."},{"key":"97513_CR22","unstructured":"Schr\u00f6dinger. Schr\u00f6dinger Release Notes - Release 2022. Schr\u00f6dinger https:\/\/www.schrodinger.com\/life-science\/download\/release-notes\/release-2022-4\/ (2022)."},{"key":"97513_CR23","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/prot.21820","volume":"71","author":"G Kieseritzky","year":"2008","unstructured":"Kieseritzky, G. & Knapp, E. W. Optimizing pKA computation in proteins with pH adapted conformations. Proteins Struct. Funct. Bioinform. 71, 1335\u20131348 (2008).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"97513_CR24","doi-asserted-by":"publisher","first-page":"107718","DOI":"10.1016\/j.jmgm.2020.107718","volume":"101","author":"S Kb","year":"2020","unstructured":"Kb, S. et al. Structure based pharmacophore modelling approach for the design of Azaindole derivatives as DprE1 inhibitors for tuberculosis. J. Mol. Graph. Model. 101, 107718 (2020).","journal-title":"J. Mol. Graph. Model."},{"key":"97513_CR25","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","volume":"35","author":"H Yang","year":"2019","unstructured":"Yang, H. et al. AdmetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35, 1067\u20131069 (2019).","journal-title":"Bioinformatics"},{"key":"97513_CR26","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"97513_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1063\/1.447334","volume":"81","author":"S Nos\u00e9","year":"1984","unstructured":"Nos\u00e9, S. A unified formulation of the constant temperature molecular dynamics methods. J. Chem. Phys. 81, 511\u2013519 (1984).","journal-title":"J. Chem. Phys."},{"key":"97513_CR28","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","volume":"31","author":"WG Hoover","year":"1985","unstructured":"Hoover, W. G. Canonical dynamics: equilibrium phase-space distributions. Phys. Rev. A. 31, 1695\u20131697 (1985).","journal-title":"Phys. Rev. A"},{"key":"97513_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"JP Ryckaert","year":"1977","unstructured":"Ryckaert, J. P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327\u2013341 (1977).","journal-title":"J. Comput. Phys."},{"key":"97513_CR30","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"97513_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"97513_CR32","unstructured":"Schr\u00f6dinger. Life Science: Prime. https:\/\/www.schrodinger.com\/platform\/products\/prime\/ (2021)."},{"key":"97513_CR33","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li, J. et al. The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins Struct. Funct. Bioinform. 79, 2794\u20132812 (2011).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"97513_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13321-021-00537-9","volume":"13","author":"SM Kohlbacher","year":"2021","unstructured":"Kohlbacher, S. M., Langer, T. & Seidel, T. QPHAR: quantitative pharmacophore activity relationship: method and validation. J. Cheminform. 13, 57 (2021).","journal-title":"J. Cheminform"},{"key":"97513_CR35","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","volume":"13","author":"K Sargsyan","year":"2017","unstructured":"Sargsyan, K., Grauffel, C. & Lim, C. How molecular size impacts RMSD applications in molecular dynamics simulations. J. Chem. Theory Comput. 13, 1518\u20131524 (2017).","journal-title":"J. Chem. Theory Comput."},{"key":"97513_CR36","doi-asserted-by":"publisher","first-page":"e0119264","DOI":"10.1371\/journal.pone.0119264","volume":"10","author":"L Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez, L. Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLOS ONE. 10, e0119264 (2015).","journal-title":"PLOS ONE"},{"key":"97513_CR37","doi-asserted-by":"publisher","first-page":"7731","DOI":"10.1039\/c3cp00116d","volume":"15","author":"F Godschalk","year":"2013","unstructured":"Godschalk, F., Genheden, S., S\u00f6derhjelm, P. & Ryde, U. Comparison of MM\/GBSA calculations based on explicit and implicit solvent simulations. Phys. Chem. Chem. Phys. 15, 7731\u20137739 (2013).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"97513_CR38","doi-asserted-by":"publisher","first-page":"12788","DOI":"10.1021\/acs.chemrev.0c00534","volume":"120","author":"S Decherchi","year":"2020","unstructured":"Decherchi, S. & Cavalli, A. Thermodynamics and kinetics of Drug-Target binding by molecular simulation. Chem. Rev. 120, 12788\u201312833 (2020).","journal-title":"Chem. Rev."},{"key":"97513_CR39","doi-asserted-by":"publisher","first-page":"107991","DOI":"10.1016\/j.compbiolchem.2023.107991","volume":"108","author":"M Jayaraman","year":"2024","unstructured":"Jayaraman, M., Gosu, V., Kumar, R. & Jeyaraman, J. Computational insights into potential marine natural products as selective inhibitors of Mycobacterium tuberculosis InhA: A structure-based virtual screening study. Comput. Biol. Chem. 108, 107991 (2024).","journal-title":"Comput. Biol. Chem."},{"key":"97513_CR40","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.3390\/molecules29204914","volume":"29","author":"M Abbas","year":"2024","unstructured":"Abbas, M. et al. Antimicrobial properties and therapeutic potential of bioactive compounds in Nigella sativa: A review. Molecules 29, 4914 (2024).","journal-title":"Molecules"},{"key":"97513_CR41","doi-asserted-by":"publisher","first-page":"107138","DOI":"10.1016\/j.bioorg.2024.107138","volume":"144","author":"EF Khaleel","year":"2024","unstructured":"Khaleel, E. F. et al. Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting Enoyl acyl carrier protein reductase (InhA). Bioorg. Chem. 144, 107138 (2024).","journal-title":"Bioorg. Chem."},{"key":"97513_CR42","doi-asserted-by":"publisher","first-page":"1424017","DOI":"10.3389\/fchem.2024.1424017","volume":"12","author":"A Sabt","year":"2024","unstructured":"Sabt, A. et al. Identification of 2-(N-aryl-1,2,3-triazol-4-yl) Quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity. Front. Chem. 12, 1424017 (2024).","journal-title":"Front. Chem."},{"key":"97513_CR43","doi-asserted-by":"publisher","first-page":"30165","DOI":"10.1039\/D4RA05616G","volume":"14","author":"T Al-Warhi","year":"2024","unstructured":"Al-Warhi, T. et al. Benzenesulfonohydrazide-tethered non-fused and fused heterocycles as potential anti-mycobacterial agents targeting Enoyl acyl carrier protein reductase (InhA) with antibiofilm activity. RSC Adv. 14, 30165\u201330179 (2024).","journal-title":"RSC Adv."},{"key":"97513_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/scipharm89020020","volume":"89","author":"DAE Pitaloka","year":"2021","unstructured":"Pitaloka, D. A. E., Ramadhan, D. S. F., Arfan, Chaidir, L. & Fakih, T. M. Docking-Based virtual screening and molecular dynamics simulations of Quercetin analogs as Enoyl-Acyl carrier protein reductase (InhA) inhibitors of Mycobacterium tuberculosis. Sci. Pharm. 89, 20 (2021).","journal-title":"Sci. Pharm."},{"key":"97513_CR45","doi-asserted-by":"crossref","unstructured":"Kamsri, P. et al. Rational design of InhA inhibitors in the class of Diphenyl ether derivatives as potential anti-tubercular agents using molecular dynamics simulations. SAR QSAR Environ. Res. (2014).","DOI":"10.1080\/1062936X.2014.898690"},{"key":"97513_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1570180816666190611153933","volume":"17","author":"AP Tiwari","year":"2020","unstructured":"Tiwari, A. P., Giliyar, V. B., Shenoy, G. G. & Eshwara, V. K. Identifying the structural features of Diphenyl ether analogues for InhA Inhibition: A 2D and 3D QSAR based study. Lett. Drug Des. Discovery. 17, 31\u201347 (2020).","journal-title":"Lett. Drug Des. Discovery"},{"key":"97513_CR47","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.240676","author":"F Shekhar, Roquet-Ban\u00e8res","year":"2024","unstructured":"Shekhar, Roquet-Ban\u00e8res, F., Anand, A., Kremer, L. & Kumar, V. Rational design and microwave-promoted synthesis of triclosan-based dimers: targeting InhA for anti-mycobacterial profiling. Royal Soc. Open. Sci. https:\/\/doi.org\/10.1098\/rsos.240676 (2024).","journal-title":"Royal Soc. Open. Sci."},{"key":"97513_CR48","doi-asserted-by":"publisher","first-page":"23695","DOI":"10.3390\/ijms161023695","volume":"16","author":"CH da Lima","year":"2015","unstructured":"da Lima, C. H. Aqueous molecular dynamics simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH system and its complex with a substrate mimic or Diphenyl ethers inhibitors. Int. J. Mol. Sci. 16, 23695\u201323722 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"97513_CR49","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10822-023-00530-4","volume":"37","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. Discovery of novel and potent InhA direct inhibitors by ensemble docking-based virtual screening and biological assays. J. Comput. Aided Mol. Des. 37, 695\u2013706 (2023).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"97513_CR50","doi-asserted-by":"publisher","first-page":"108573","DOI":"10.1016\/j.compbiomed.2024.108573","volume":"176","author":"RV Chikhale","year":"2024","unstructured":"Chikhale, R. V. et al. Identification of novel hit molecules targeting M. tuberculosis polyketide synthase 13 by combining generative AI and physics-based methods. Comput. Biol. Med. 176, 108573 (2024).","journal-title":"Comput. Biol. Med."},{"key":"97513_CR51","doi-asserted-by":"publisher","first-page":"110370","DOI":"10.1016\/j.dib.2024.110370","volume":"54","author":"H Taniguchi","year":"2024","unstructured":"Taniguchi, H., Kawamoto, S., Monobe, K. & Aoki, S. Data on molecular Docking and molecular dynamics targeting Mycobacterium tuberculosis Shikimic acid kinase. Data Brief. 54, 110370 (2024).","journal-title":"Data Brief."},{"key":"97513_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2024.2319678","author":"S\u0130 Dingi\u015f Birg\u00fcl","year":"2024","unstructured":"Dingi\u015f Birg\u00fcl, S. \u0130 et al. In silico design, synthesis and antitubercular activity of novel 2-acylhydrazono-5-arylmethylene-4-thiazolidinones as enoyl-acyl carrier protein reductase inhibitors. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2024.2319678 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"97513_CR53","doi-asserted-by":"publisher","first-page":"109245","DOI":"10.1016\/j.compbiomed.2024.109245","volume":"183","author":"S Moradi","year":"2024","unstructured":"Moradi, S. et al. A review on description dynamics and conformational changes of proteins using combination of principal component analysis and molecular dynamics simulation. Comput. Biol. Med. 183, 109245 (2024).","journal-title":"Comput. Biol. Med."},{"key":"97513_CR54","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1080\/07391102.2020.1712258","volume":"39","author":"S Nirwan","year":"2021","unstructured":"Nirwan, S., Chahal, V. & Kakkar, R. Structure-based virtual screening, free energy of binding and molecular dynamics simulations to propose novel inhibitors of Mtb-MurB oxidoreductase enzyme. J. Biomol. Struct. Dyn. 39, 656\u2013671 (2021).","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97513-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97513-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97513-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T10:01:39Z","timestamp":1744624899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97513-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97513"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97513-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12795"}}